Takeda Pharmaceutical Co Ltd (OTC Pink - Current Information:TKPHF)
| 32.13 Delayed Data As of May 30 |  -0.19 / -0.59%Today’s Change | 25.07 Today|||52-Week Range 34.47 | +3.65% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $51.1B |
Company Description
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Contact Information
Takeda Pharmaceutical Co., Ltd. 4-1-1 Dosho-machi Osaka Osaka 540-8645 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Christophe Weber | President, CEO & Representative Director |
| Constantine Saroukos | Chief Financial Officer & Director |
| Andrew S. Plump | Director, President-Research & Development |
| Michael E. Mendelsohn | Chief Medical & Scientific Officer |
| Norimasa Takeda | Chief Accounting Officer & Corporate Controller |
